A fully-automated low-cost cardiac monolayer optical mapping robot.
automation
calcium sensitive dyes
cardiac electrophysiology
genetically encoded voltage indicators
optical mapping
robotics
voltage sensitive dyes
Journal
Frontiers in cardiovascular medicine
ISSN: 2297-055X
Titre abrégé: Front Cardiovasc Med
Pays: Switzerland
ID NLM: 101653388
Informations de publication
Date de publication:
2023
2023
Historique:
received:
12
11
2022
accepted:
24
04
2023
medline:
7
6
2023
pubmed:
7
6
2023
entrez:
7
6
2023
Statut:
epublish
Résumé
Scalable and high-throughput electrophysiological measurement systems are necessary to accelerate the elucidation of cardiac diseases in drug development. Optical mapping is the primary method of simultaneously measuring several key electrophysiological parameters, such as action potentials, intracellular free calcium and conduction velocity, at high spatiotemporal resolution. This tool has been applied to isolated whole-hearts, whole-hearts in-vivo, tissue-slices and cardiac monolayers/tissue-constructs. Although optical mapping of all of these substrates have contributed to our understanding of ion-channels and fibrillation dynamics, cardiac monolayers/tissue-constructs are scalable macroscopic substrates that are particularly amenable to high-throughput interrogation. Here, we describe and validate a scalable and fully-automated monolayer optical mapping robot that requires no human intervention and with reasonable costs. As a proof-of-principle demonstration, we performed parallelized macroscopic optical mapping of calcium dynamics in the well-established neonatal-rat-ventricular-myocyte monolayer plated on standard 35 mm dishes. Given the advancements in regenerative and personalized medicine, we also performed parallelized macroscopic optical mapping of voltage dynamics in human pluripotent stem cell-derived cardiomyocyte monolayers using a genetically encoded voltage indictor and a commonly-used voltage sensitive dye to demonstrate the versatility of our system.
Identifiants
pubmed: 37283579
doi: 10.3389/fcvm.2023.1096884
pmc: PMC10240081
doi:
Types de publication
Journal Article
Langues
eng
Pagination
1096884Informations de copyright
© 2023 Lee, Hou, Alibhai, Al-attar, Simon-Chica, Redondo-Rodriguez, Nie, Mirotsou, Laflamme, Swaminath and Filgueiras-Rama.
Déclaration de conflit d'intérêts
PL is both an owner and employee of Essel Research and Development Inc. LH, YN, MM and GS are employees of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc., Rahway, NJ, USA. MAL is a scientific founder and paid consultant for BlueRock Therapeutics LP. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
Int J Biochem Cell Biol. 2020 Sep;126:105804
pubmed: 32681973
Sci Rep. 2019 Feb 4;9(1):1389
pubmed: 30718782
J Bioeng Biomed Sci. 2015 Nov;5(3):
pubmed: 28451466
J Pharmacol Toxicol Methods. 2016 Sep-Oct;81:240-50
pubmed: 27184445
Circ Res. 2012 Jun 8;110(12):1556-63
pubmed: 22570367
Front Physiol. 2021 Sep 03;12:692496
pubmed: 34539428
Sci Rep. 2022 Mar 7;12(1):3678
pubmed: 35256624
Prog Biophys Mol Biol. 2020 Aug;154:62-70
pubmed: 30850184
Sci Rep. 2015 Nov 17;5:16647
pubmed: 26573336
Front Physiol. 2021 Aug 20;12:696270
pubmed: 34489722
Nat Commun. 2016 May 10;7:11542
pubmed: 27161419
Nat Commun. 2020 Jan 7;11(1):75
pubmed: 31911598
Methods Mol Biol. 2014;1181:229-47
pubmed: 25070341
Curr Opin Chem Biol. 2017 Aug;39:1-10
pubmed: 28460291
Pflugers Arch. 2012 Oct;464(4):403-14
pubmed: 22886365
Front Physiol. 2021 Nov 18;12:769586
pubmed: 34867476
Circ Res. 2004 Jul 9;95(1):21-33
pubmed: 15242982
Cell Rep. 2018 Sep 25;24(13):3582-3592
pubmed: 30257217
Assay Drug Dev Technol. 2017 May/Jun;15(4):178-188
pubmed: 28525289
J Tissue Eng Regen Med. 2011 Jun;5(6):e115-25
pubmed: 21604379
Circ Res. 2010 Dec 10;107(12):1503-11
pubmed: 20947828
J Biomed Opt. 2023 Jan;28(1):016001
pubmed: 36636698
Cold Spring Harb Perspect Med. 2014 Mar 01;4(3):
pubmed: 24591534
Front Physiol. 2019 Mar 07;10:182
pubmed: 30899227
Circulation. 2022 May 3;145(18):1412-1426
pubmed: 35089805
Stem Cell Reports. 2015 Apr 14;4(4):621-31
pubmed: 25801505
PLoS One. 2017 Aug 24;12(8):e0183761
pubmed: 28837652
Circ Res. 2012 Feb 17;110(4):609-23
pubmed: 22343556
Heart Rhythm. 2012 Dec;9(12):2077-82
pubmed: 23108055
Br J Pharmacol. 2011 Mar;162(6):1239-49
pubmed: 21091654
Sci Rep. 2016 Apr 20;6:24726
pubmed: 27095412
Circ Arrhythm Electrophysiol. 2009 Apr;2(2):185-94
pubmed: 19808464
J Vis Exp. 2015 May 14;(99):e52755
pubmed: 26068617
Nat Neurosci. 2014 Jun;17(6):884-9
pubmed: 24755780
Nat Commun. 2019 Sep 20;10(1):4325
pubmed: 31541103
J Cardiovasc Electrophysiol. 2000 Jun;11(6):665-76
pubmed: 10868740
Am J Physiol Heart Circ Physiol. 2016 Jul 1;311(1):H44-53
pubmed: 27199128
J Electrocardiol. 2006 Oct;39(4 Suppl):S2-6
pubmed: 17015066
Am J Physiol Heart Circ Physiol. 2015 May 1;308(9):H1112-25
pubmed: 25595366
Cardiovasc Res. 2004 May 1;62(2):287-98
pubmed: 15094349
Sci Rep. 2017 Feb 27;7:43217
pubmed: 28240274
Biotechnol Adv. 2017 Jan - Feb;35(1):77-94
pubmed: 28007615
PLoS One. 2021 Jun 2;16(6):e0251812
pubmed: 34077426
J Mol Cell Cardiol. 2012 Nov;53(5):657-67
pubmed: 22921230